| Issue Date | Title | Author(s) |
| 2015 | Acute kidney injury in China: a cross-sectional survey | Yang, Li; Xing, Guolan; Wang, Li; Wu, Yonggui; Li, Suhua; Xu, Gang; He, Qiang; Chen, Jianghua; Chen, Menghua; Liu, Xiaohua; Zhu, Zaizhi; Yang, Lin; Lian, Xiyan; Ding, Feng; Li, Yun; Wang, Huamin; Wang, Jianqin; Wang, Rong; Mei, Changlin; Xu, Jixian; Li, Rongshan; Cao, Juan; Zhang, Liang; Wang, Yan; Xu, Jinhua; Bao, Beiyan; Liu, Bicheng; Chen, Hongyu; Li, Shaomei; Zha, Yan; Luo, Qiong; Chen, Dongcheng; Shen, Yulan; Liao, Yunhua; Zhang, Zhengrong; Wang, Xianqiu; Zhang, Kun; Liu, Luojin; Mao, Peiju; Guo, Chunxiang; Li, Jiangang; Wang, Zhenfu; Bai, Sho |
| Dec-2023 | Central administration of Dapagliflozin alleviates a hypothalamic neuroinflammatory signature and changing tubular lipid metabolism in type 2 diabetic nephropathy by upregulating MCPIP1 | Da, Jingjing; Xu, Yongjie; Tan, Ying; Zhang, Jiqin; Yu, Jiali; Zhao, Jianqiu; Da, Qingen; Yu, Fuxun; Zha, Yan |
| May-2020 | Executive Summary: Clinical Practice Guideline for Autosomal Dominant Polycystic Kidney Disease in China | Mei, Chang-Lin; Xue, Cheng; Yu, Sheng-Qiang; Dai, Bing; Chen, Jiang-Hua; Li, Ying; Chen, Li-Meng; Liu, Zhang-Suo; Wu, Yong-Gui; Hu, Zhao; Zha, Yan; Liu, Hong; Zhuang, Yong-Ze; Zhang, Chun; Xiao, Xiang-Cheng; Wang, Yue; Li, Gui-Sen; Ma, Yi-Yi; Li, Lin |
| 2019 | Leflunomide versus cyclophosphamide in the induction treatment of proliferative lupus nephritis in Chinese patients: a randomized trial | Zhang, Minfang; Qi, Chaojun; Zha, Yan; Chen, Jian; Luo, Ping; Wang, Li; Sun, Zhuxing; Wan, Jianxin; Xing, Changying; Wang, Song; Jiang, Gengru; Sun, Mindan; Chen, Qinkai; Chen, Jianghua; Li, Detian; Guan, Tianjun; Ni, Zhaohui |
| 2023 | Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League | Liu, Jing; Li, Yan; Zhang, Xinjun; Bu, Peili; Du, Xueping; Fang, Lizheng; Feng, Yingqing; Guo, Yifang; Han, Fei; Jiang, Yinong; Li, Yuming; Lin, Jinxiu; Liu, Min; Liu, Wei; Long, Mingzhi; Mu, Jianjun; Sun, Ningling; Wu, Hao; Xie, Jianhong; Xie, Jingyuan; Xie, Liangdi; Yu, Jing; Yuan, Hong; Zha, Yan; Zhang, Yuqing; Zhu, Shanzhu; Wang, Jiguang |
| Jun-2023 | THE TYPE. ANTI-CD20MONOCLONAL ANTIBODY MIL62 OR CYCLOSPORINE IN CHINESE PRIMARY MEMBRANOUS NEPHROPATHY: PRELIMINARY RESULTS OF A PHASE IB/II TRIAL | Cui, Zhao; Zhang, Yimiao; Li, Heng; Zhou, Hua; Lin, Hongli; Xing, Guangqun; Chen, Wei; Liang, Wei; Luo, Ping; Chen, Xiaolan; Xu, Hui; Zha, Yan; Wang, Yue; Chen, Xing; Ni, Zhaohui; Zhang, Junjun; Lu, Wanhong; Zhang, Haitao; Long, Haibo; Sun, Dong; Cao, Yu; Zhao, Minghui; Meng, Song; Wei, Min |
| Mar-2020 | Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression | Yang, Xiaobing; Ou, Jun; Zhang, Hong; Xu, Xin; Zhu, Li; Li, Qingchu; Li, Jiaxin; Xie, Di; Sun, Jingdi; Zha, Yan; Li, Yang; Tian, Jianwei; Liu, Youhua; Hou, Fan Fan |
